Skip to main content
. 2020 Oct 6;21(19):7379. doi: 10.3390/ijms21197379

Figure 1.

Figure 1

Combination index (CI) values for combination treatment with poziotinib and CCBs in ovarian cancer cells and ovarian CSCs.